OREX: OREXIGEN THERAPEUTICS INC Real-Time Headlines

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

Symbol	Value	Change	Percentage Change
DJIA	10,023.42	17.46	0.17%
NASDAQ	2,112.44	7.12	0.34%
S&P 500	1,069.30	2.67	0.25%

Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Learn More

Get the FREE DailyFinance iPhone application

OREXIGEN THERAPEUTICS INC

OREX

Stock price

7.05 -0.01 -0.14%

as of 04:00 PM EST on 11/06/2009 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

7.28 0.23 3.26%

as of 08:37 AM EST on 11/09/09

Analyst Consensus

Strong Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts

OREXIGEN THERAPEUTICS INC Real-Time Headlines

Customize
Thursday, November 5, 2009

Orexigen Therapeutics Inc. Reports Operating Results (10-Q)

11/5/09 | GuruFocus

SEC Filing: Quarterly Financials

11/5/09 View all Related Articles > | Thomson Financial

Orexigen 3rd-quarter loss narrows on lower costs

11/5/09 | AP ONLINE

Wednesday, November 4, 2009

Orexigen (OREX) Reports Q3 Loss of $0.33, Beats by 3c

11/4/09 | StreetInsider.com

Orexigen reports Q3 EPS (33c) vs. consensus of (36c)

11/4/09 | Theflyonthewall.com

Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results

11/4/09 | StockWatch

Vivus shares dive following 3rd-quarter report

11/4/09 | AP ONLINE

Tuesday, November 3, 2009

Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals ..

11/3/09 View all Related Articles > | PR-inside - Austria

Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals

11/3/09 | Business Wire

Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals - Press Releases

11/3/09 | Zacks Investment Research

Monday, November 2, 2009

Pharma's big movers: Amylin up on obesity drug, Hep C drug lifts Vertex

11/2/09 | DailyFinance

Thursday, October 29, 2009

Orexigen(R) Therapeutics Schedules November 4, 2009 Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2009

10/29/09 | PR Newswire

Wednesday, October 28, 2009

Diet pills: Vivus, Arena and Orexigen in race to market safe weight-loss drugs

10/28/09 View all Related Articles > | DailyFinance

Tuesday, October 27, 2009

Orexigen releases new efficacy data for Contrave

10/27/09 | Theflyonthewall.com

Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society

10/27/09 | PR Newswire

Monday, October 26, 2009

Lazard Capital hosts an analyst Healthcare/industry conference call

10/26/09 | Theflyonthewall.com

Orexigen CEO Sounds Off

10/26/09 | CNBC Video

Saving Health Care Dollars...and Lives

10/26/09 | CNBC Video

Orexigen Therapeutics, Inc. Obesity Drug Shows Added Benefits

10/26/09 View all Related Articles > | Pharm Country

Trimming the Health Care Fat

10/26/09 | CNBC Video

Orexigen announces new data that shows weight loss with Contrave

10/26/09 | Theflyonthewall.com

Sunday, October 25, 2009

Orexigen presents new Contrave data

10/25/09 | Theflyonthewall.com

Saturday, October 24, 2009

Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk

10/24/09 | PR Newswire

Wednesday, October 21, 2009

Orexigen(R) Therapeutics Announces Contrave(R) Data Presentations at Annual Scientific Meeting of The Obesity Society

10/21/09 View all Related Articles > | StockWatch

Orexigen(R) Therapeutics Announces Contrave(R) Data Presentations at Annual Scientific Meeting of The Obesity Society

10/21/09 | PR Newswire

Tuesday, October 20, 2009

Galleon's Biotech Stock Holdings: BioBuzz

10/20/09 | TheStreet.com

Wednesday, October 14, 2009

Tomorrow's Monster Stock?

10/14/09 | The Motley Fool

Orexigen management to meet with Lazard Capital

10/14/09 | Theflyonthewall.com

Tuesday, October 13, 2009

FMR Corp. reports passive 14.784% Orexigen stake

10/13/09 | Theflyonthewall.com

SEC Filing: Greater than or Equal to 5% Acquisition

10/13/09 | Thomson Financial

Friday, October 9, 2009

Biotech Mailbag: Transdel Pharma

10/9/09 | TheStreet.com

Thursday, October 8, 2009

3 Stocks in a Tailspin

10/8/09 | The Motley Fool

Friday, October 2, 2009

Orexigen's second anti-obesity drug passes Phase IIb trial

10/2/09 View all Related Articles > | Script World Pharmaceutical News - UK

Thursday, October 1, 2009

Orexigen(R) Therapeutics to Speak at JMP Securities Healthcare Focus Conference

10/1/09 | PR Newswire

SEC Filing: Current Event

10/1/09 View all Related Articles > | Thomson Financial

Wednesday, September 30, 2009

Onyx Pharma Holds Conference Call Too Late: BioBuzz

9/30/09 | TheStreet.com

Orexigen announces results of Phase 2b Empatic trial

9/30/09 | Theflyonthewall.com

Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients

9/30/09 | PR Newswire

Orexigen to host conference call

9/30/09 | Theflyonthewall.com

Tuesday, September 29, 2009

Orexigen to announce results of Phase 2 trail of Empatic on September 30

9/29/09 | Theflyonthewall.com

1 <Next>
Thursday, November 5, 2009

Orexigen Therapeutics Inc. Reports Operating Results (10-Q)

11/5/09 | GuruFocus

SEC Filing: Quarterly Financials

11/5/09 View all News Related Articles > | Thomson Financial

Orexigen 3rd-quarter loss narrows on lower costs

11/5/09 | AP ONLINE

Wednesday, November 4, 2009

Orexigen reports Q3 EPS (33c) vs. consensus of (36c)

11/4/09 | Theflyonthewall.com

Vivus shares dive following 3rd-quarter report

11/4/09 | AP ONLINE

Tuesday, November 3, 2009

Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals - Press Releases

11/3/09 | Zacks Investment Research

Monday, November 2, 2009

Pharma's big movers: Amylin up on obesity drug, Hep C drug lifts Vertex

11/2/09 | DailyFinance

Wednesday, October 28, 2009

Diet pills: Vivus, Arena and Orexigen in race to market safe weight-loss drugs

10/28/09 View all News Related Articles > | DailyFinance

Tuesday, October 27, 2009

Orexigen releases new efficacy data for Contrave

10/27/09 | Theflyonthewall.com

Monday, October 26, 2009

Lazard Capital hosts an analyst Healthcare/industry conference call

10/26/09 | Theflyonthewall.com

Orexigen CEO Sounds Off

10/26/09 | CNBC Video

Saving Health Care Dollars...and Lives

10/26/09 | CNBC Video

Trimming the Health Care Fat

10/26/09 | CNBC Video

Orexigen announces new data that shows weight loss with Contrave

10/26/09 | Theflyonthewall.com

Sunday, October 25, 2009

Orexigen presents new Contrave data

10/25/09 | Theflyonthewall.com

Saturday, October 24, 2009

Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk

10/24/09 View all News Related Articles > | StockHouse

Tuesday, October 20, 2009

Galleon's Biotech Stock Holdings: BioBuzz

10/20/09 | TheStreet.com

Wednesday, October 14, 2009

Tomorrow's Monster Stock?

10/14/09 | The Motley Fool

Orexigen management to meet with Lazard Capital

10/14/09 | Theflyonthewall.com

Tuesday, October 13, 2009

FMR Corp. reports passive 14.784% Orexigen stake

10/13/09 | Theflyonthewall.com

SEC Filing: Greater than or Equal to 5% Acquisition

10/13/09 | Thomson Financial

Friday, October 9, 2009

Biotech Mailbag: Transdel Pharma

10/9/09 | TheStreet.com

Thursday, October 8, 2009

3 Stocks in a Tailspin

10/8/09 | The Motley Fool

Thursday, October 1, 2009

SEC Filing: Current Event

10/1/09 View all News Related Articles > | Thomson Financial

Wednesday, September 30, 2009

Movers roundup: Allscripts-Misys, Orexigen

9/30/09 View all News Related Articles > | AP ONLINE

Onyx Pharma Holds Conference Call Too Late: BioBuzz

9/30/09 | TheStreet.com

Orexigen announces results of Phase 2b Empatic trial

9/30/09 | Theflyonthewall.com

Orexigen to host conference call

9/30/09 | Theflyonthewall.com

Tuesday, September 29, 2009

Orexigen to announce results of Phase 2 trail of Empatic on September 30

9/29/09 | Theflyonthewall.com

Wednesday, September 23, 2009

SEC Filing: Insider Buy/Sell

9/23/09 | Thomson Financial

Tuesday, September 22, 2009

SEC Filing: Restricted Stk. Sale

9/22/09 View all News Related Articles > | Thomson Financial

Orexigen Therapeutics Set 11 1/2 Month High Monday

9/22/09 | RTTNews

Friday, September 18, 2009

Up, Down, Up. Is This Stock a Home Run or Not?

9/18/09 | The Motley Fool

SEC Filing: Insider Buy/Sell

9/18/09 View all News Related Articles > | Thomson Financial

Sector Snap: Trio of obesity drug makers

9/18/09 View all News Related Articles > | AP ONLINE

Diet Drug News: Arena Pharma

9/18/09 | CNBC Video

Arena obesity drug falls short against other meds

9/18/09 | AP ONLINE

Thursday, September 17, 2009

SEC Filing: Restricted Stk. Sale

9/17/09 View all News Related Articles > | Thomson Financial

Tuesday, September 15, 2009

Arena falls after downgrade on obesity drug view

9/15/09 View all News Related Articles > | AP ONLINE

Monday, September 14, 2009

SEC Filing: Restricted Stk. Sale

9/14/09 View all News Related Articles > | Thomson Financial

1 <Next>
Wednesday, November 4, 2009

Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results

11/4/09 | StockWatch

Tuesday, November 3, 2009

Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals ..

11/3/09 | PR-inside - Austria

Monday, October 26, 2009

Orexigen Therapeutics, Inc. Obesity Drug Shows Added Benefits

10/26/09 View all Trade Related Articles > | Pharm Country

Wednesday, October 21, 2009

Orexigen(R) Therapeutics Announces Contrave(R) Data Presentations at Annual Scientific Meeting of The Obesity Society

10/21/09 | StockWatch

Friday, October 2, 2009

Orexigen's second anti-obesity drug passes Phase IIb trial

10/2/09 View all Trade Related Articles > | Script World Pharmaceutical News - UK

Tuesday, September 22, 2009

Zacks Analyst Blog Highlights: Fairfax Financial, Odyssey Re, Arena, Vivus and Orexigen

9/22/09 | PR-inside - Austria

Wednesday, September 16, 2009

Orexigen(R) Therapeutics to Speak at UBS Global Life Sciences Conference

9/16/09 | StockWatch

Wednesday, September 9, 2009

Orexigen(R) Therapeutics to Speak at Upcoming Conferences

9/9/09 | StockWatch

Monday, August 24, 2009

Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer

8/24/09 | StockWatch

Thursday, August 6, 2009

Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results

8/6/09 View all Trade Related Articles > | StockWatch

Tuesday, August 4, 2009

Orexigen(R) Therapeutics Schedules August 6, 2009 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2009

8/4/09 | StockWatch

Thursday, July 23, 2009

Orexigen Therapeutics, Inc. Prices 10M Share Offering at $7.50

7/23/09 View all Trade Related Articles > | BioSpace

Orexigen Therapeutics, Repligen and Affymetrix lead small-cap volume in pre-market

7/23/09 | SmallCapInvestor

Wednesday, July 22, 2009

Orexigen Therapeutics, Oriental Financial Group and Imation lead small-cap percentage gainers

7/22/09 | SmallCapInvestor

Monday, July 20, 2009

Orexigen Therapeutics, Landrys Restaurants and Santander Bancorp lead small-cap percentage gainers

7/20/09 | SmallCapInvestor

Orexigen Therapeutics, Spectrum Pharmaceuticals and PetMed Express lead small-cap percentage losers

7/20/09 | SmallCapInvestor

STOCKS NEWS US-Orexigen shares rise after trial data

7/20/09 View all Trade Related Articles > | Interactive Investor - UK

Orexigen Reports Success In 3 Large Trials Of Obesity Drug

7/20/09 View all Trade Related Articles > | NASDAQ

Friday, July 17, 2009

UPDATE 1-Orexigen to unveil obesity trial results on Monday

7/17/09 | Interactive Investor - UK

Monday, July 13, 2009

OREXIGEN THERAPEUTICS - Newly Released Company Financials and Credit Information (Published 14th June 2009)

7/13/09 | PR-inside - Austria

Wednesday, July 8, 2009

Websense, Orexigen Therapeutics and Pzena Investment Management lead small-cap percentage losers

7/8/09 | SmallCapInvestor

Friday, June 12, 2009

Orexigen Signs Licensing Agreement With GSK

6/12/09 | Pharmaceutical Business Review Online - UK

Thursday, June 11, 2009

Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)

6/11/09 View all Trade Related Articles > | StockWatch

Saturday, June 6, 2009

Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions

6/6/09 View all Trade Related Articles > | StockWatch

Wednesday, May 13, 2009

Orexigen(R) Therapeutics to Present at Upcoming Meetings

5/13/09 View all Trade Related Articles > | StockWatch

Monday, May 11, 2009

Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy

5/11/09 View all Trade Related Articles > | StockWatch

Friday, May 8, 2009

Orexigen(R) Therapeutics to Speak at Upcoming Conferences

5/8/09 View all Trade Related Articles > | StockWatch

Thursday, May 7, 2009

Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results

5/7/09 View all Trade Related Articles > | StockWatch

Monday, April 27, 2009

Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program

4/27/09 | The Pink Sheet Daily

Wednesday, April 1, 2009

Orexigen Therapeutics, Inc. Names 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer

4/1/09 View all Trade Related Articles > | BioSpace

Tuesday, March 31, 2009

Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer

3/31/09 | The Pink Sheet Daily

Monday, March 16, 2009

Orexigen(R) Therapeutics to Speak at Cowen & Company Healthcare Conference

3/16/09 | The Pink Sheet Daily

Tuesday, March 10, 2009

Orexigen Therapeutics Schedules March 12, 2009 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2008

3/10/09 | PharmaLive

Monday, March 9, 2009

Orexigen(R) Therapeutics Schedules March 12, 2009 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2008

3/9/09 View all Trade Related Articles > | StockWatch

Monday, March 2, 2009

Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors

3/2/09 | The Pink Sheet Daily

Wednesday, February 4, 2009

Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference

2/4/09 | The Pink Sheet Daily

Monday, January 12, 2009

Orexigen Therapeutics, Inc. (OREX) Announces First Of Four Phase 3 Trials Of Contrave(R) Meets Co-Primary And Key Secondary

1/12/09 | Biocompare

Friday, January 9, 2009

DryShips, Orexigen Therapeutics and Greenlight Capital Re lead small-cap volume in pre-market

1/9/09 | SmallCapInvestor

Orexigen Therapeutics Inc is down 31.4% to $4.15 in pre-market trading, after a report last night that the results of a weight-loss drug fell short of fed requirements.

1/9/09 View all Trade Related Articles > | SmallCapInvestor

Thursday, January 8, 2009

Orexigen obesity drug leads to 9.3 pct weight loss

1/8/09 View all Trade Related Articles > | Interactive Investor - UK

1 <Next>
Wednesday, September 30, 2009

Orexigen's Obesity Drug Empatic Meets Study Goal

9/30/09 View all Regional Related Articles > | NBC - KSBW - TV 8 - Salinas CA

Wednesday, September 9, 2009

Vivus, Rival to Arena and Orexigen, Nails Big Results in Clinical Trials of Obesity Drug

9/9/09 View all Regional Related Articles > | The San Diego Union Tribune - San Diego CA

Wednesday, September 2, 2009

Orexigen Aims to Redefine Obesity, as Amgen Vet Revamps Company to Compete

9/2/09 | The San Diego Union Tribune - San Diego CA

Monday, July 20, 2009

Orexigen's Contrave Takes Off The Weight

7/20/09 View all Regional Related Articles > | ABC - KMBC-TV - Kansas City MO

Thursday, January 8, 2009

Orexigen Obesity Drug Falls Shy Of FDA Standard

1/8/09 View all Regional Related Articles > | NBC - WPTZ NewsChannel 5 - Plattsburgh NY

Tuesday, May 27, 2008

Orexigen wins patent covering lead obesity drug

5/27/08 View all Regional Related Articles > | The Boston Globe - Boston MA

Wednesday, May 7, 2008

Orexigen Therapeutics completes enrollment in phase 3 clinical program

5/7/08 | San Diego Daily Transcript - San Diego CA

Tuesday, April 22, 2008

Morning Briefing: Orexigen completes enrollment in second Phase 3 clinical trial

4/22/08 | San Diego Daily Transcript - San Diego CA

Orexigen completes enrollment in second Phase 3 clinical trials

4/22/08 | San Diego Daily Transcript - San Diego CA

Thursday, March 13, 2008

Orexigen Therapeutics' three-month net loss improves, but higher for the year

3/13/08 | San Diego Daily Transcript - San Diego CA

Thursday, January 24, 2008

Orexigen prices stock offering at $11

1/24/08 | The Boston Globe - Boston MA

Monday, January 14, 2008

Orexigen leases in Torrey Pines Court

1/14/08 | San Diego Daily Transcript - San Diego CA

Monday, November 12, 2007

Orexigen Therapeutics, Akesis Pharmaceuticals

11/12/07 | San Diego Daily Transcript - San Diego CA

Briefly: Orexigen Therapeutics, Akesis Pharmaceuticals

11/12/07 | San Diego Daily Transcript - San Diego CA

Wednesday, October 17, 2007

Phenomix, Orexigen, Seacoast Commerce Bank

10/17/07 | San Diego Daily Transcript - San Diego CA

1
Tuesday, November 3, 2009

Zacks Analyst Blog Highlights: Clorox Company, Arena Pharmaceuticals, Vivus Inc., Orexigen Therapeutics and Amylin Pharmaceuticals

11/3/09 | Business Wire

Thursday, October 29, 2009

Orexigen(R) Therapeutics Schedules November 4, 2009 Webcast Discussion of Financial Results for the Third Quarter Ended September 30, 2009

10/29/09 | PR Newswire

Tuesday, October 27, 2009

Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society

10/27/09 | PR Newswire

Saturday, October 24, 2009

Orexigen(R) Therapeutics Presents New Data Showing Weight Loss with Contrave Significantly Improves Important Markers of Cardiometabolic Risk

10/24/09 | PR Newswire

Wednesday, October 21, 2009

Orexigen(R) Therapeutics Announces Contrave(R) Data Presentations at Annual Scientific Meeting of The Obesity Society

10/21/09 | PR Newswire

Thursday, October 1, 2009

Orexigen(R) Therapeutics to Speak at JMP Securities Healthcare Focus Conference

10/1/09 | PR Newswire

Tuesday, September 22, 2009

Zacks Analyst Blog Highlights: Fairfax Financial, Odyssey Re, Arena, Vivus and Orexigen

9/22/09 | Business Wire

Wednesday, September 16, 2009

Orexigen(R) Therapeutics to Speak at UBS Global Life Sciences Conference

9/16/09 | PR Newswire

Wednesday, September 9, 2009

Orexigen(R) Therapeutics to Speak at Upcoming Conferences

9/9/09 | PR Newswire

Thursday, September 3, 2009

Orexigen(R) Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference

9/3/09 | PR Newswire

Monday, August 24, 2009

Orexigen(R) Therapeutics Appoints Mark Booth Chief Commercial Officer

8/24/09 | PR Newswire

Wednesday, August 5, 2009

Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference

8/5/09 | PR Newswire

Tuesday, August 4, 2009

Orexigen(R) Therapeutics Schedules August 6, 2009 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2009

8/4/09 | PR Newswire

Wednesday, July 22, 2009

Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock

7/22/09 | PR Newswire

Monday, July 20, 2009

-Contrave(R) Obesity Research Phase 3 Program Meets Co-Primary and Key Secondary Endpoints; Exceeds FDA Efficacy Benchmark for Obesity Treatments-

7/20/09 | PR Newswire

Friday, July 17, 2009

Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results

7/17/09 | PR Newswire

Thursday, June 11, 2009

Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)

6/11/09 | PR Newswire

Saturday, June 6, 2009

Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions

6/6/09 | PR Newswire

Tuesday, June 2, 2009

Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings

6/2/09 | PR Newswire

Wednesday, May 13, 2009

Orexigen(R) Therapeutics to Present at Upcoming Meetings

5/13/09 | PR Newswire

Monday, May 11, 2009

Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy

5/11/09 | PR Newswire

Friday, May 8, 2009

Live Updates:

Ticker

Dynamic view of the market

OREXIGEN THERAPEUTICS INC

OREX

Stock price

Extended Hours

OREXIGEN THERAPEUTICS INC Real-Time Headlines

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Thursday, October 29, 2009

Wednesday, October 28, 2009

Tuesday, October 27, 2009

Monday, October 26, 2009

Sunday, October 25, 2009

Saturday, October 24, 2009

Wednesday, October 21, 2009

Tuesday, October 20, 2009

Wednesday, October 14, 2009

Tuesday, October 13, 2009

Friday, October 9, 2009

Thursday, October 8, 2009

Friday, October 2, 2009

Thursday, October 1, 2009

Wednesday, September 30, 2009

Tuesday, September 29, 2009

Thursday, November 5, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, November 2, 2009

Wednesday, October 28, 2009

Tuesday, October 27, 2009

Monday, October 26, 2009

Sunday, October 25, 2009

Saturday, October 24, 2009

Tuesday, October 20, 2009

Wednesday, October 14, 2009

Tuesday, October 13, 2009

Friday, October 9, 2009

Thursday, October 8, 2009

Thursday, October 1, 2009

Wednesday, September 30, 2009

Tuesday, September 29, 2009

Wednesday, September 23, 2009

Tuesday, September 22, 2009

Friday, September 18, 2009

Thursday, September 17, 2009

Tuesday, September 15, 2009

Monday, September 14, 2009

Wednesday, November 4, 2009

Tuesday, November 3, 2009

Monday, October 26, 2009

Wednesday, October 21, 2009

Friday, October 2, 2009

Tuesday, September 22, 2009

Wednesday, September 16, 2009

Wednesday, September 9, 2009

Monday, August 24, 2009